Novartis Ag (NVS) FCF Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 1,688.00 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -1,334.00 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1,096.00 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -672.00 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1,020.00 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -518.00 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 1,090.00 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 869.00 |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 2,747.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -672.00 |
| Mar 31, 2026 | 121.00 |
| Dec 31, 2025 | 1,930.00 |
| Sep 30, 2025 | -174.00 |
| Jun 30, 2025 | 873.00 |
| Mar 31, 2025 | 840.00 |
| Dec 31, 2024 | -1,480.00 |
| Sep 30, 2024 | 366.00 |
| Jun 30, 2024 | 781.00 |
| Mar 31, 2024 | -787.00 |
| Dec 31, 2023 | 523.00 |
| Sep 30, 2023 | 76.00 |
| Jun 30, 2023 | 184.00 |
| Mar 31, 2023 | 1,373.00 |
| Dec 31, 2022 | 1,315.00 |
| Sep 30, 2022 | 661.00 |
| Jun 30, 2022 | -320.00 |
| Mar 31, 2022 | -393.00 |
| Dec 31, 2021 | 553.00 |
| Sep 30, 2021 | 1,247.00 |